MCL1 and neoplasm: However, the average volume of the tumors in the mice that were treated with vemurafenib and Mcl-1 siRNA was 292 ± 48.12 mm3, showing a notable suppression of tumor growth by more than 80%, as compared to control or vemurafenib treated group (Fig. 6A).